Wednesday, February 10, 2010, 2:35am EST - Canadian Markets open in 6 hours and 55 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Bond Laboratories, Inc. (BNLB.OB)

On Feb 9: 0.49 USD  Up 0.01 (2.08%)  
MORE ON BNLB.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
BOND LABORATORIES (OTC BB:BNLB.OB) Delayed quote dataEdit
Last Trade: 0.49 USD
Trade Time: Feb 9
Change: Up 0.01 (2.08%)
Prev Close: 0.48
Open: 0.48
Bid: 0.43 x 5000
Ask: 0.54 x 2500
1y Target Est: N/A
Day's Range: 0.48 - 0.51
52wk Range: 0.10 - 1.60
Volume: 50,400
Avg Vol (3m): 44,582.5
Market Cap: 26.24M
P/E (ttm): N/A
EPS (ttm): -0.27
Div & Yield: N/A (N/A%)
Bond Laboratories, Inc. (BNLB.OB)
1d  5d  3m  6m  1y  2y 
 Add BNLB.OB to Portfolio   Download Data

HEADLINES
Bond Labs Expands Resurrection Footprint in Tennessee
Business Wire (Wed, Feb 3)
BOND LABORATORIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Mon, Feb 1)
Bond Labs Announces 70% Increase in Revenue for the Fourth Quarter
Business Wire (Thu, Jan 28)
Bond Labs Extends Resurrection Anti-Hangover Drink Distribution into Tennessee
Business Wire (Tue, Jan 26)
BOND LABORATORIES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Mon, Jan 25)
Bond Labs Reports Strong Revenue Growth During First Year of NDS Nutrition Products, Inc. Ownership
Business Wire (Wed, Jan 20)
Bond Laboratories Continues Midwest March with Announcement of Their First Distributor in Nebraska
Business Wire (Thu, Jan 14)
Bond Laboratories Continues its Drive Across the Southeast with Another Miller-Coors Distributor in Virginia
PRNewswire (Tue, Jan 12)
Executive Interview: Uplift Nutrition, Inc. - Edward Hall, Chairman And Majority Shareholder
Wall Street Transcript (Thu, Dec 24)
Bond Laboratories Recaps Successful First 100 Days for Resurrection
Business Wire (Tue, Dec 22)
More Headlines for BNLB.OB...

ANALYST
EPS Est (next year) (Dec-69) : N/A
EPS Est (in 2 years) (Dec-69) : N/A
Avg Rec (current)*: N/A
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Bond Laboratories, Inc., a development stage company, manufactures and markets healthy food and beverage products in the United States. It focuses on developing proprietary products and delivery platforms principally in energy, pain relief, and we...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices